SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

A Wells Fargo analyst downgrade to Underweight is driving the attention and sharp selling in Netflix, with traders also debating the conflicting bullish Evercore view. The community is split between bearish concerns about slowing growth, valuation and persistent weakness, and buyers citing advertising growth, buybacks, live sports and strong earnings as reasons to accumulate the dip.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

Ultragenyxs full FDA approval of Fayuvi, the first treatment for Sanfilippo syndrome type A, is driving attention, with traders highlighting the new commercial opportunity and accompanying Priority Review Voucher. The community is broadly bullish but debates whether the stocks muted reaction reflects limited patient numbers, commercialization and cash-burn concerns, or potential short-covering and further institutional interest.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

A sharp NEAR rally is driving momentum and short-squeeze speculation, with bullish traders highlighting the tokens AI, chain-abstraction and NEAR Intents utility. Skeptics argue the move is largely liquidity- or whale-driven and warn that it may be a pump without a clear catalyst.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

A reported but unverified plan for AMD to raise prices on some AI accelerators and graphics products, attributed to higher TSMC wafer costs, is adding to a broader AI-chip rebound. Traders are largely bullish on momentum, short-squeeze and call activity, while some warn the move is overextended and vulnerable to profit-taking.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Anticipation of HLP003s Phase 3 readout is driving attention, reinforced by completed enrollment, conference commentary from the new CEO, and reported insider buying. Traders are bullish on the drugs earlier efficacy signals and potential psychedelic-sector re-rating, while skeptics cite clinical-stage uncertainty and future dilution risk.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Anticipation of a long-delayed Judge Andrews ruling in Liquidias patent litigation with United Therapeutics is driving attention, with traders treating the decision as a binary catalyst and debating whether it will clear YUTREPIAs legal overhang or create downside risk. The discussion also cites continued YUTREPIA adoption and commercial growth, though some traders view the recent strength as overextended and favor puts or profit-taking while the ruling remains unresolved.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Uniswaps reported Robinhood Chain integration and activated fee-switch/buyback-and-burn narrative are driving attention, with traders viewing potential tokenized-asset volume and reduced supply as bullish. The community remains divided, as some expect further momentum while others flag overbought conditions, profit-taking, and possible pullbacks.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Strong Q2 results, improved margins, raised guidance, and the expansion of Velo3Ds Livermore production campus have fueled attention, with traders viewing accelerating aerospace and defense demand as a potential growth catalyst. The community remains divided between bullish momentum and short-squeeze expectations versus concerns about profitability, contract visibility, accounting, and the stocks volatile post-earnings reaction.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

SpaceXs plans to expand Starlink into a full mobile network are driving attention, with traders debating whether the service could take meaningful wireless customers from AT&T or remains a long-term, capital-intensive threat. Bullish participants point to AT&Ts strong wireless and fiber additions, cash flow, buybacks and satellite partnerships as offsets, while others remain concerned about intensified telecom competition.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Speculation about a potential pharmaceutical buyout is driving attention, supported by Vandas NEREUS launch, planned BYSANTI rollout and late-stage pipeline, particularly the GLP-1-related nausea program. Traders are divided, with bullish participants emphasizing pipeline and acquisition value while skeptics focus on heavy marketing spending, cash burn, payer access and management execution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
